It really is a big quality of life difference, because we are putting so much effort into getting SMI patients to engage more with the real world, Sokolin said
In recent years, tirzepatide has emerged as a promising treatment option for individuals living with this chronic disease
Yes, but you must be diligent with sun protection
#AhmedInsights #Type2Diabetes #Ozempic #Trulicity #Mounjaro #IncretinScience #CardioMetabolicHealth #MedicalEducation #GCCProfessionals #Pharmarketing To view or add a comment, sign in A potentially important shift in the obesity treatment market is emerging from new late-phase trial data announced by Eli Lilly and Company
Here's what the trials have shown: Phase 1b Trial Results (Lancet 2022) The initial Phase 1b study evaluated retatrutide safety, tolerability, and pharmacokinetics in 72 adults with type 2 diabetes over 12 weeks
One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems